Drawing for VUTRYM

USPTO serial 78337449

VUTRYM

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BORSUK, ESTHER
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VUTRYM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gordon E. R. Troy

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and nutraceutical preparations, namely therapeutic systems in the form of a bandage, cream, ointment or patch for transdermal or transmucosal delivery of single and multi-component nutritional and dietary supplements and substances including vitamins, derivatives, mixtures, and formulations thereof; Pharmaceutical and nutraceutical preparations made with plants and plant extracts in patch form for medical purposes for treatment of hair and skin disorders, insomnia, fatigue, hypertension, weight control, rheumatism, circulatory disorders, bronchial disorders, and digestive disorders, in bandage, cream, ointment or patch form for dietetic and medical purposes, and for nutritional purposes; pharmaceutical preparations for the treatment of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders, coughs, colds, influenza, headaches, stomach and digestive disorders, muscular and/or rheumatic disorders, anti-inflammatory agents, immune system disorders and related diseases, allergic reactions, metabolic disorders, anti-infective, ocular disorders, and for use in oncology; diagnostic preparations and/or reagents for clinical or medical laboratory use; Nicotine for medicinal purposes in transdermal patch form; Hormones; Dietetic substances for medical purposes, namely, nutritional, vitamin, herbal and mineral supplements and preparations; pharmaceutical preparations, namely, for transdermal administration in a patch formulation and as a cream, and an ointment, used in the treatment of the hormonal replacement therapy or for the treatment of osteoarticular diseases; Nutritional supplements, namely, nutraceutical preparations including extracts, isolates and concentratesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 20, 2007MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 20, 2007ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 30, 2007EX5GSOU EXTENSION 5 GRANTED—
May 30, 2007EXT5SOU EXTENSION 5 FILED—
May 30, 2007EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 27, 2006EX4GSOU EXTENSION 4 GRANTED—
Nov 27, 2006EXT4SOU EXTENSION 4 FILED—
Nov 27, 2006EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 30, 2006EX3GSOU EXTENSION 3 GRANTED—
May 30, 2006EXT3SOU EXTENSION 3 FILED—
May 30, 2006EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 19, 2005EX2GSOU EXTENSION 2 GRANTED—
Nov 28, 2005EXT2SOU EXTENSION 2 FILED—
Nov 28, 2005EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 25, 2005EX1GSOU EXTENSION 1 GRANTED—
May 25, 2005EXT1SOU EXTENSION 1 FILED—
May 25, 2005EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 30, 2004NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 7, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 18, 2004NPUBNOTICE OF PUBLICATION—
Jun 24, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 24, 2004DOCKASSIGNED TO EXAMINER—
Jan 2, 2004NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance